Figure 2 from Development and Validation of a Multimodal–Multitask Deep Learning Approach for Estimating Late Distant Recurrence Risk in HR-Positive Early Breast Cancer

Authors:
Open Access
Publisher website
Google Scholar
Abstract
Kaplan–Meier analysis of DR in the NSABP B-42 translational cohort according to MI Clarity M3T risk groups. A, All patients. B, ELT-treated group. C, Placebo group. High- and low-risk groups are defined by the M3T model.